ReNew Energy Global’s first-quarter revenue reaches INR 47.9 billion, driven by growth in wind, solar, and hydro assets, though its financial health remains under scrutiny despite investor optimism.
ReNew Energy Global said on August 18, 2026 that first-quarter revenue rose to INR 47.9 billion from INR 41.2 billion a year earlier, underscoring the pace of expansion in India’s renewable power market. The increase reflects stronger output from the company’s wind, solar and hydro portfolio, alongside a broader push into digital services and carbon-market offerings, according to the company and industry reporting.
Even so, the stock’s valuation picture remains mixed. GuruFocus said RNW’s price-to-sales ratio stood at 1.69, below its historical median of about 2.2 times, while earnings-based measures remain of limited use because the company is still loss-making and cash-flow negative. Macrotrends and CompaniesMarketCap also show the ratio has drifted lower over the past year, suggesting investors are paying less for each dollar of sales than they have historically.
GuruFocus places RNW’s GF Value at $8.92 a share, roughly 23.5% above the quoted price of $6.82, indicating modest apparent undervaluation. The same analysis gives RNW a GF Score of 85 out of 100, with strong marks for growth and profitability but a weak score for financial strength. That weakness is not trivial: GuruFocus cites high leverage, thin interest coverage and an Altman Z-score that points to distress risk.
There are, however, signs that some sophisticated investors remain constructive. GuruFocus said three premium gurus currently hold the shares, and all three have added recently rather than reduced exposure. That comes as ReNew’s latest operating results have improved sharply: Reuters and sector reports said the company delivered record annual profit in fiscal 2026, helped by higher operating income, manufacturing sales and more capacity coming on stream. ReNew also commissioned 2.4 gigawatts of capacity during the year and plans to add more solar-cell manufacturing by December 2026, suggesting the business is still scaling even as its balance-sheet pressures linger.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
